https://infektiopedia.de/w/index.php?action=history&feed=atom&title=DGI%3AOpportunistische_Infektionen%2FCMV%2FQuellen DGI:Opportunistische Infektionen/CMV/Quellen - Versionsgeschichte 2026-09-04T23:19:23Z Versionsgeschichte dieser Seite in Infektiopedia MediaWiki 1.43.9 https://infektiopedia.de/w/index.php?title=DGI:Opportunistische_Infektionen/CMV/Quellen&diff=8153&oldid=prev Kristina.jozic am 4. August 2026 um 11:07 Uhr 2026-08-04T11:07:56Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de-x-formal"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 4. August 2026, 11:07 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Zeile 1:</td> <td colspan="2" class="diff-lineno">Zeile 1:</td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*<del style="font-weight: bold; text-decoration: none;">&lt;nowiki&gt;https://www</del>.<del style="font-weight: bold; text-decoration: none;">rki</del>.<del style="font-weight: bold; text-decoration: none;">de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Zytomegalievirus</del>.<del style="font-weight: bold; text-decoration: none;">html;jsessionid=13FA88DA454E7CD74309C4050B66B0D2</del>.<del style="font-weight: bold; text-decoration: none;">internet082#doc4738494bodyText10&lt;/nowiki&gt;</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*<del style="font-weight: bold; text-decoration: none;">&lt;nowiki&gt;https://www</del>.<del style="font-weight: bold; text-decoration: none;">uniklinikum</del>-<del style="font-weight: bold; text-decoration: none;">saarland</del>.<del style="font-weight: bold; text-decoration: none;">de/fileadmin/UKS/Einrichtungen/Kliniken_und_Institute/Infektionsmedizin/Prof_Transplantation/Diagnostik/2019_Schmidt_Sester_CME_CMV</del>.<del style="font-weight: bold; text-decoration: none;">pdf&lt;/nowiki&gt;</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* <ins style="font-weight: bold; text-decoration: none;">Robert Koch-Institut. RKI-Ratgeber Zytomegalievirus-Infektion</ins>. <ins style="font-weight: bold; text-decoration: none;">Stand 24</ins>.<ins style="font-weight: bold; text-decoration: none;">10</ins>.<ins style="font-weight: bold; text-decoration: none;">2023</ins>.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*<del style="font-weight: bold; text-decoration: none;">&lt;nowiki&gt;https://www</del>.<del style="font-weight: bold; text-decoration: none;">dgho</del>.<del style="font-weight: bold; text-decoration: none;">de/publikationen/stellungnahmen/fruehe-nutzenbewertung/copy_of_letermovir/letermovir-dgho-dag-kbt-stellungnahme-20180605</del>.<del style="font-weight: bold; text-decoration: none;">pdf&lt;/nowiki&gt;</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* <ins style="font-weight: bold; text-decoration: none;">Kotton CN, Kumar D, Caliendo AM, et al</ins>. <ins style="font-weight: bold; text-decoration: none;">The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid</ins>-<ins style="font-weight: bold; text-decoration: none;">organ Transplantation. Transplantation</ins>. <ins style="font-weight: bold; text-decoration: none;">2018;102(6):900–931</ins>.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*<del style="font-weight: bold; text-decoration: none;">Brodt</del>, <del style="font-weight: bold; text-decoration: none;">Hans Reinhardt: Stille Antibiotika Therapie</del>, <del style="font-weight: bold; text-decoration: none;">Klinik und Praxis der antiinfektiösen Behandlung. 2 Auflage.</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* <ins style="font-weight: bold; text-decoration: none;">Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients – Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice</ins>. <ins style="font-weight: bold; text-decoration: none;">Clin Transplant</ins>. <ins style="font-weight: bold; text-decoration: none;">2019;33(9):e13512</ins>.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">*Hoffmann C. &amp; Rockstroh</del>, <del style="font-weight: bold; text-decoration: none;">J</del>.: <del style="font-weight: bold; text-decoration: none;">HIV 2020/ 2021</del>. <del style="font-weight: bold; text-decoration: none;">www</del>.<del style="font-weight: bold; text-decoration: none;">hivbuch</del>.<del style="font-weight: bold; text-decoration: none;">de</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* <ins style="font-weight: bold; text-decoration: none;">Limaye AP</ins>, <ins style="font-weight: bold; text-decoration: none;">Budde K</ins>, <ins style="font-weight: bold; text-decoration: none;">Humar A</ins>, <ins style="font-weight: bold; text-decoration: none;">et al</ins>. <ins style="font-weight: bold; text-decoration: none;">Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients</ins>: <ins style="font-weight: bold; text-decoration: none;">A Randomized Clinical Trial</ins>. <ins style="font-weight: bold; text-decoration: none;">JAMA</ins>. <ins style="font-weight: bold; text-decoration: none;">2023;330(1):33–42</ins>.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*<del style="font-weight: bold; text-decoration: none;">Dante </del>P <del style="font-weight: bold; text-decoration: none;">Melendez and Raymund R Razonable: </del>Letermovir <del style="font-weight: bold; text-decoration: none;">and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus; Infect Drug Resist</del>. <del style="font-weight: bold; text-decoration: none;">2015</del>; <del style="font-weight: bold; text-decoration: none;">8</del>: <del style="font-weight: bold; text-decoration: none;">269–277</del>. <del style="font-weight: bold; text-decoration: none;">Published online 2015 Aug 5</del>. <del style="font-weight: bold; text-decoration: none;">doi</del>: <del style="font-weight: bold; text-decoration: none;">10</del>.<del style="font-weight: bold; text-decoration: none;">2147/IDR</del>.<del style="font-weight: bold; text-decoration: none;">S79131 PMCID: PMC4531042</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* <ins style="font-weight: bold; text-decoration: none;">Marty FM, Ljungman </ins>P<ins style="font-weight: bold; text-decoration: none;">, Chemaly RF, et al. </ins>Letermovir <ins style="font-weight: bold; text-decoration: none;">Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. N Engl J Med</ins>. <ins style="font-weight: bold; text-decoration: none;">2017</ins>;<ins style="font-weight: bold; text-decoration: none;">377(25)</ins>:<ins style="font-weight: bold; text-decoration: none;">2433–2444</ins>.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">*&lt;nowiki&gt;https</del>:<del style="font-weight: bold; text-decoration: none;">//next.amboss</del>.<del style="font-weight: bold; text-decoration: none;">com/de/article/nf0752#Z33d59c26da10cb6030670c9557deb5e5&lt;/nowiki&gt;</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">* Avery RK, Alain S, Alexander BD, et al</ins>. <ins style="font-weight: bold; text-decoration: none;">Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant</ins>: <ins style="font-weight: bold; text-decoration: none;">Results From a Phase 3 Randomized Clinical Trial (SOLSTICE)</ins>. <ins style="font-weight: bold; text-decoration: none;">Clin Infect Dis</ins>. <ins style="font-weight: bold; text-decoration: none;">2022;75(4)</ins>:<ins style="font-weight: bold; text-decoration: none;">690–701</ins>.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*<del style="font-weight: bold; text-decoration: none;">&lt;nowiki&gt;https://www</del>.<del style="font-weight: bold; text-decoration: none;">ncbi</del>.<del style="font-weight: bold; text-decoration: none;">nlm</del>.<del style="font-weight: bold; text-decoration: none;">nih</del>.<del style="font-weight: bold; text-decoration: none;">gov/pmc/articles/PMC6431500/&lt;/nowiki&gt;</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* <ins style="font-weight: bold; text-decoration: none;">Papanicolaou GA, Avery RK, Cordonnier C, et al</ins>. <ins style="font-weight: bold; text-decoration: none;">Maribavir versus Valganciclovir for First CMV Infection Post-Hematopoietic Cell Transplant (AURORA)</ins>. <ins style="font-weight: bold; text-decoration: none;">Clin Infect Dis</ins>. <ins style="font-weight: bold; text-decoration: none;">2024;78(3):562–572</ins>.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*<del style="font-weight: bold; text-decoration: none;">Munro M</del>, <del style="font-weight: bold; text-decoration: none;">Yadavalli T</del>, <del style="font-weight: bold; text-decoration: none;">Fonteh </del>C, <del style="font-weight: bold; text-decoration: none;">Arfeen S, Lobo-Chan AM: Cytomegalovirus Retinitis </del>in <del style="font-weight: bold; text-decoration: none;">HIV </del>and <del style="font-weight: bold; text-decoration: none;">Non</del>-<del style="font-weight: bold; text-decoration: none;">HIV Individuals</del>. <del style="font-weight: bold; text-decoration: none;">Microorganisms</del>. 2019 <del style="font-weight: bold; text-decoration: none;">Dec 28</del>;8<del style="font-weight: bold; text-decoration: none;">(1</del>):<del style="font-weight: bold; text-decoration: none;">55. doi: 10.3390/microorganisms8010055</del>.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* <ins style="font-weight: bold; text-decoration: none;">Ljungman P</ins>, <ins style="font-weight: bold; text-decoration: none;">de la Camara R</ins>, <ins style="font-weight: bold; text-decoration: none;">Robin </ins>C, <ins style="font-weight: bold; text-decoration: none;">et al. Guidelines for the management of cytomegalovirus infection </ins>in <ins style="font-weight: bold; text-decoration: none;">patients with haematological malignancies </ins>and <ins style="font-weight: bold; text-decoration: none;">after stem cell transplantation (ECIL</ins>-<ins style="font-weight: bold; text-decoration: none;">7)</ins>. <ins style="font-weight: bold; text-decoration: none;">Lancet Infect Dis</ins>. 2019;<ins style="font-weight: bold; text-decoration: none;">19(</ins>8):<ins style="font-weight: bold; text-decoration: none;">e260–e272</ins>.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*<del style="font-weight: bold; text-decoration: none;">&lt;nowiki&gt;https://www</del>.<del style="font-weight: bold; text-decoration: none;">awmf</del>.<del style="font-weight: bold; text-decoration: none;">org/uploads/tx_szleitlinien/093-002l_S2k_Virusinfektionen-Organtransplantierte-alloge-Stammzell-Transplantierten-Diagnostik-Praevention-Therapie__2019-06</del>.<del style="font-weight: bold; text-decoration: none;">pdf&lt;/nowiki&gt;</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>* <ins style="font-weight: bold; text-decoration: none;">Fryer JF, Heath AB, Minor P, et al</ins>. <ins style="font-weight: bold; text-decoration: none;">A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology</ins>. <ins style="font-weight: bold; text-decoration: none;">Biologicals</ins>. <ins style="font-weight: bold; text-decoration: none;">2016;44(4)</ins>:<ins style="font-weight: bold; text-decoration: none;">242–251</ins>.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">*&lt;nowiki&gt;https</del>:<del style="font-weight: bold; text-decoration: none;">//www.aerzteblatt.de/nachrichten/126064/CMV-Hyperimmunglobulin-kann-Fetopathie-in-der-Schwangerschaft-nicht-verhindern&lt;/nowiki&gt;</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">*&lt;nowiki&gt;https://www.nejm.org/doi/full/10</del>.<del style="font-weight: bold; text-decoration: none;">1056/NEJMoa1913569&lt;/nowiki&gt;</del></div></td><td colspan="2" class="diff-side-added"></td></tr> </table> Kristina.jozic https://infektiopedia.de/w/index.php?title=DGI:Opportunistische_Infektionen/CMV/Quellen&diff=8152&oldid=prev Bestem am 30. November 2021 um 16:17 Uhr 2021-11-30T16:17:48Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de-x-formal"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 30. November 2021, 16:17 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Zeile 1:</td> <td colspan="2" class="diff-lineno">Zeile 1:</td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"># </del>&lt;nowiki&gt;https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Zytomegalievirus.html;jsessionid=13FA88DA454E7CD74309C4050B66B0D2.internet082#doc4738494bodyText10&lt;/nowiki&gt;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*</ins>&lt;nowiki&gt;https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Zytomegalievirus.html;jsessionid=13FA88DA454E7CD74309C4050B66B0D2.internet082#doc4738494bodyText10&lt;/nowiki&gt;</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"># </del>&lt;nowiki&gt;https://www.uniklinikum-saarland.de/fileadmin/UKS/Einrichtungen/Kliniken_und_Institute/Infektionsmedizin/Prof_Transplantation/Diagnostik/2019_Schmidt_Sester_CME_CMV.pdf&lt;/nowiki&gt;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*</ins>&lt;nowiki&gt;https://www.uniklinikum-saarland.de/fileadmin/UKS/Einrichtungen/Kliniken_und_Institute/Infektionsmedizin/Prof_Transplantation/Diagnostik/2019_Schmidt_Sester_CME_CMV.pdf&lt;/nowiki&gt;</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"># </del>&lt;nowiki&gt;https://www.dgho.de/publikationen/stellungnahmen/fruehe-nutzenbewertung/copy_of_letermovir/letermovir-dgho-dag-kbt-stellungnahme-20180605.pdf&lt;/nowiki&gt;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*</ins>&lt;nowiki&gt;https://www.dgho.de/publikationen/stellungnahmen/fruehe-nutzenbewertung/copy_of_letermovir/letermovir-dgho-dag-kbt-stellungnahme-20180605.pdf&lt;/nowiki&gt;</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"># </del>Brodt, Hans Reinhardt: Stille Antibiotika Therapie, Klinik und Praxis der antiinfektiösen Behandlung. 2 Auflage.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*</ins>Brodt, Hans Reinhardt: Stille Antibiotika Therapie, Klinik und Praxis der antiinfektiösen Behandlung. 2 Auflage.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"># </del>Hoffmann C. &amp; Rockstroh, J.: HIV 2020/ 2021. www.hivbuch.de</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*</ins>Hoffmann C. &amp; Rockstroh, J.: HIV 2020/ 2021. www.hivbuch.de</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"># </del>Dante P Melendez and Raymund R Razonable: Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus; Infect Drug Resist. 2015; 8: 269–277. Published online 2015 Aug 5. doi: 10.2147/IDR.S79131 PMCID: PMC4531042</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*</ins>Dante P Melendez and Raymund R Razonable: Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus; Infect Drug Resist. 2015; 8: 269–277. Published online 2015 Aug 5. doi: 10.2147/IDR.S79131 PMCID: PMC4531042</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"># </del>&lt;nowiki&gt;https://next.amboss.com/de/article/nf0752#Z33d59c26da10cb6030670c9557deb5e5&lt;/nowiki&gt;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*</ins>&lt;nowiki&gt;https://next.amboss.com/de/article/nf0752#Z33d59c26da10cb6030670c9557deb5e5&lt;/nowiki&gt;</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"># </del>&lt;nowiki&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431500/&lt;/nowiki&gt;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*</ins>&lt;nowiki&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431500/&lt;/nowiki&gt;</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"># </del>Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan AM: Cytomegalovirus Retinitis in HIV and Non-HIV Individuals. Microorganisms. 2019 Dec 28;8(1):55. doi: 10.3390/microorganisms8010055.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*</ins>Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan AM: Cytomegalovirus Retinitis in HIV and Non-HIV Individuals. Microorganisms. 2019 Dec 28;8(1):55. doi: 10.3390/microorganisms8010055.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"># </del>&lt;nowiki&gt;https://www.awmf.org/uploads/tx_szleitlinien/093-002l_S2k_Virusinfektionen-Organtransplantierte-alloge-Stammzell-Transplantierten-Diagnostik-Praevention-Therapie__2019-06.pdf&lt;/nowiki&gt;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*</ins>&lt;nowiki&gt;https://www.awmf.org/uploads/tx_szleitlinien/093-002l_S2k_Virusinfektionen-Organtransplantierte-alloge-Stammzell-Transplantierten-Diagnostik-Praevention-Therapie__2019-06.pdf&lt;/nowiki&gt;</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"># </del>&lt;nowiki&gt;https://www.aerzteblatt.de/nachrichten/126064/CMV-Hyperimmunglobulin-kann-Fetopathie-in-der-Schwangerschaft-nicht-verhindern&lt;/nowiki&gt;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*</ins>&lt;nowiki&gt;https://www.aerzteblatt.de/nachrichten/126064/CMV-Hyperimmunglobulin-kann-Fetopathie-in-der-Schwangerschaft-nicht-verhindern&lt;/nowiki&gt;</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"># </del>&lt;nowiki&gt;https://www.nejm.org/doi/full/10.1056/NEJMoa1913569&lt;/nowiki&gt;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*</ins>&lt;nowiki&gt;https://www.nejm.org/doi/full/10.1056/NEJMoa1913569&lt;/nowiki&gt;</div></td></tr> </table> Bestem https://infektiopedia.de/w/index.php?title=DGI:Opportunistische_Infektionen/CMV/Quellen&diff=8151&oldid=prev Bestem am 24. November 2021 um 15:51 Uhr 2021-11-24T15:51:10Z <p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de-x-formal"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 24. November 2021, 15:51 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Zeile 1:</td> <td colspan="2" class="diff-lineno">Zeile 1:</td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Zytomegalievirus.html;jsessionid=13FA88DA454E7CD74309C4050B66B0D2.internet082#doc4738494bodyText10</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"># &lt;nowiki&gt;</ins>https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Zytomegalievirus.html;jsessionid=13FA88DA454E7CD74309C4050B66B0D2.internet082#doc4738494bodyText10<ins style="font-weight: bold; text-decoration: none;">&lt;/nowiki&gt;</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>https://www.uniklinikum-saarland.de/fileadmin/UKS/Einrichtungen/Kliniken_und_Institute/Infektionsmedizin/Prof_Transplantation/Diagnostik/2019_Schmidt_Sester_CME_CMV.pdf</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"># &lt;nowiki&gt;</ins>https://www.uniklinikum-saarland.de/fileadmin/UKS/Einrichtungen/Kliniken_und_Institute/Infektionsmedizin/Prof_Transplantation/Diagnostik/2019_Schmidt_Sester_CME_CMV.pdf<ins style="font-weight: bold; text-decoration: none;">&lt;/nowiki&gt;</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>https://www.dgho.de/publikationen/stellungnahmen/fruehe-nutzenbewertung/copy_of_letermovir/letermovir-dgho-dag-kbt-stellungnahme-20180605.pdf</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"># &lt;nowiki&gt;</ins>https://www.dgho.de/publikationen/stellungnahmen/fruehe-nutzenbewertung/copy_of_letermovir/letermovir-dgho-dag-kbt-stellungnahme-20180605.pdf<ins style="font-weight: bold; text-decoration: none;">&lt;/nowiki&gt;</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Brodt, Hans Reinhardt: Stille Antibiotika Therapie, Klinik und Praxis der antiinfektiösen Behandlung. 2 Auflage.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"># </ins>Brodt, Hans Reinhardt: Stille Antibiotika Therapie, Klinik und Praxis der antiinfektiösen Behandlung. 2 Auflage.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Hoffmann C. &amp; Rockstroh, J.: HIV 2020/ 2021. www.hivbuch.de</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"># </ins>Hoffmann C. &amp; Rockstroh, J.: HIV 2020/ 2021. www.hivbuch.de</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Dante P Melendez and Raymund R Razonable: Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus; Infect Drug Resist. 2015; 8: 269–277. Published online 2015 Aug 5. doi: 10.2147/IDR.S79131 PMCID: PMC4531042</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"># </ins>Dante P Melendez and Raymund R Razonable: Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus; Infect Drug Resist. 2015; 8: 269–277. Published online 2015 Aug 5. doi: 10.2147/IDR.S79131 PMCID: PMC4531042</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>https://next.amboss.com/de/article/nf0752#Z33d59c26da10cb6030670c9557deb5e5</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"># &lt;nowiki&gt;</ins>https://next.amboss.com/de/article/nf0752#Z33d59c26da10cb6030670c9557deb5e5<ins style="font-weight: bold; text-decoration: none;">&lt;/nowiki&gt;</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431500/</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"># &lt;nowiki&gt;</ins>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431500/<ins style="font-weight: bold; text-decoration: none;">&lt;/nowiki&gt;</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan AM: Cytomegalovirus Retinitis in HIV and Non-HIV Individuals. Microorganisms. 2019 Dec 28;8(1):55. doi: 10.3390/microorganisms8010055.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"># </ins>Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan AM: Cytomegalovirus Retinitis in HIV and Non-HIV Individuals. Microorganisms. 2019 Dec 28;8(1):55. doi: 10.3390/microorganisms8010055.</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>https://www.awmf.org/uploads/tx_szleitlinien/093-002l_S2k_Virusinfektionen-Organtransplantierte-alloge-Stammzell-Transplantierten-Diagnostik-Praevention-Therapie__2019-06.pdf</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"># &lt;nowiki&gt;</ins>https://www.awmf.org/uploads/tx_szleitlinien/093-002l_S2k_Virusinfektionen-Organtransplantierte-alloge-Stammzell-Transplantierten-Diagnostik-Praevention-Therapie__2019-06.pdf<ins style="font-weight: bold; text-decoration: none;">&lt;/nowiki&gt;</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>https://www.aerzteblatt.de/nachrichten/126064/CMV-Hyperimmunglobulin-kann-Fetopathie-in-der-Schwangerschaft-nicht-verhindern</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"># &lt;nowiki&gt;</ins>https://www.aerzteblatt.de/nachrichten/126064/CMV-Hyperimmunglobulin-kann-Fetopathie-in-der-Schwangerschaft-nicht-verhindern<ins style="font-weight: bold; text-decoration: none;">&lt;/nowiki&gt;</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>https://www.nejm.org/doi/full/10.1056/NEJMoa1913569</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"># &lt;nowiki&gt;</ins>https://www.nejm.org/doi/full/10.1056/NEJMoa1913569<ins style="font-weight: bold; text-decoration: none;">&lt;/nowiki&gt;</ins></div></td></tr> </table> Bestem https://infektiopedia.de/w/index.php?title=DGI:Opportunistische_Infektionen/CMV/Quellen&diff=8150&oldid=prev Bestem: Die Seite wurde neu angelegt: „https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Zytomegalievirus.html;jsessionid=13FA88DA454E7CD74309C4050B66B0D2.internet082#doc4738494bod…“ 2021-11-24T15:50:32Z <p>Die Seite wurde neu angelegt: „https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Zytomegalievirus.html;jsessionid=13FA88DA454E7CD74309C4050B66B0D2.internet082#doc4738494bod…“</p> <p><b>Neue Seite</b></p><div>https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Zytomegalievirus.html;jsessionid=13FA88DA454E7CD74309C4050B66B0D2.internet082#doc4738494bodyText10<br /> https://www.uniklinikum-saarland.de/fileadmin/UKS/Einrichtungen/Kliniken_und_Institute/Infektionsmedizin/Prof_Transplantation/Diagnostik/2019_Schmidt_Sester_CME_CMV.pdf<br /> https://www.dgho.de/publikationen/stellungnahmen/fruehe-nutzenbewertung/copy_of_letermovir/letermovir-dgho-dag-kbt-stellungnahme-20180605.pdf<br /> Brodt, Hans Reinhardt: Stille Antibiotika Therapie, Klinik und Praxis der antiinfektiösen Behandlung. 2 Auflage.<br /> Hoffmann C. &amp; Rockstroh, J.: HIV 2020/ 2021. www.hivbuch.de<br /> Dante P Melendez and Raymund R Razonable: Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus; Infect Drug Resist. 2015; 8: 269–277. Published online 2015 Aug 5. doi: 10.2147/IDR.S79131 PMCID: PMC4531042<br /> https://next.amboss.com/de/article/nf0752#Z33d59c26da10cb6030670c9557deb5e5<br /> https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431500/<br /> Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan AM: Cytomegalovirus Retinitis in HIV and Non-HIV Individuals. Microorganisms. 2019 Dec 28;8(1):55. doi: 10.3390/microorganisms8010055.<br /> https://www.awmf.org/uploads/tx_szleitlinien/093-002l_S2k_Virusinfektionen-Organtransplantierte-alloge-Stammzell-Transplantierten-Diagnostik-Praevention-Therapie__2019-06.pdf<br /> https://www.aerzteblatt.de/nachrichten/126064/CMV-Hyperimmunglobulin-kann-Fetopathie-in-der-Schwangerschaft-nicht-verhindern<br /> https://www.nejm.org/doi/full/10.1056/NEJMoa1913569</div> Bestem